Article in Epigenomics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
13 authors.
Min Kyung LeeDepartment of Epidemiology, Geisel School of Medicine at Dartmouth, Lebanon, NH 03755, USA.ORCID 0000-0001-9558-4819
Ze ZhangDepartment of Epidemiology, Geisel School of Medicine at Dartmouth, Lebanon, NH 03755, USA.ORCID 0000-0001-9854-5823
Kartik SehgalDepartment of Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02215, USA.ORCID 0000-0003-4391-6943
Rondi ButlerDepartment of Epidemiology, Brown University School of Public Health, Providence, RI 02903, USA.ORCID 0000-0002-6474-8953
Hannah StolrowDepartment of Epidemiology, Geisel School of Medicine at Dartmouth, Lebanon, NH 03755, USA.ORCID 0009-0002-0002-4128
Geat RamushDepartment of Epidemiology, Brown University School of Public Health, Providence, RI 02903, USA.
Keisuke ShiraiDepartment of Medicine, Dartmouth Hitchcock Medical Center, Lebanon, NH 03766, USA.ORCID 0000-0002-1403-8128
Devin C KoestlerDepartment of Biostatistics & Data Science, University of Kansas Medical Center, Kansas City, KS 66103, USA.ORCID 0000-0002-0598-0146
Lucas A SalasDepartment of Epidemiology, Geisel School of Medicine at Dartmouth, Lebanon, NH 03755, USA.ORCID 0000-0002-2279-4097
John K WienckeDepartment of Neurological Surgery, University of California San Francisco, San Francisco, CA 94143, USA.ORCID 0000-0001-7101-6489
Robert HaddadDepartment of Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02215, USA.ORCID 0000-0003-1413-0079
Karl T KelseyDepartment of Epidemiology, Brown University School of Public Health, Providence, RI 02903, USA.ORCID 0000-0002-2302-1600
Brock C ChristensenDepartment of Epidemiology, Geisel School of Medicine at Dartmouth, Lebanon, NH 03755, USA.ORCID 0000-0003-3022-426X
Funding
Translational Engineering in Cancer (TEC)P30CA023108 · NCI · DARTMOUTH COLLEGE · PI Fred W Kolling IV · 1985 to 2026
$91.3M
Transgenic & Gene-Targeting Shared ResourceP30CA168524 · NCI · UNIVERSITY OF KANSAS MEDICAL CENTER · PI ROY A. JENSEN · 2012 to 2026
$40.1M
DNA-based Immune Phenotyping in HNSCC for Biomarkers of Response to ImmunotherapyR01CA253976 · NCI · BROWN UNIVERSITY · PI CHRISTENSEN, BROCK C, KELSEY, KARL TIMOTHY · 2021 to 2025
$3.3M
(PQ3) Immune epigenetic biomarkers of bladder cancer outcomesR01CA216265 · NCI · DARTMOUTH COLLEGE · PI CHRISTENSEN, BROCK CLARKE · 2017 to 2021
DNA MethylationHead and Neck NeoplasmsImmune Checkpoint InhibitorsSquamous Cell Carcinoma of Head and NeckAgedCancer SurvivorsCD8-Positive T-LymphocytesFemaleHumansKiller Cells, NaturalMaleMiddle AgedImmune Checkpoint InhibitorsDNA methylationhead and neck squamous cell carcinomaimmune checkpoint inhibitorsimmune profilesimmunomethylomicsmethylation cytometry
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.
Immunomethylomic profiles of long-term head and neck squamous cell carcinoma survivors on immune checkpoint inhibitors. · full record | Socratic